Abstract:Introduction: Arsenic (As) exposure is associated with lung toxicity and we aim to investigate the effects of arsenic exposure on lung fibrotic changes. Methods: Participants (n= 976) enrolled via a general health survey underwent chest low-dose computed tomography (LDCT), spirometry forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and urinary arsenic examination during 2016 and 2018. Lung fibrotic changes from LDCT were defined. As LtoL , low arsenic levels in both 2016 and 2018; As LtoH , low arsenic in 2016 but high levels in 2018; As HtoL , high arsenic in 2016 but low levels in 2018; As HtoH , high arsenic levels in both 2016 and 2018. Mice exposed to 0. 0.2mg/L, 2 mg/L, 50 mg/L of sodium arsenite (NaAsO 2 ) through drinking water for 12 weeks and 24 weeks were applied for histological analysis. Cultured lung epithelial cells were exposed to NaAsO 2 and the mesenchymal changes were examined. Results: As HtoH increased the risk (OR= 1.65, 95% CI 1.10, 2.49) of Lung fibrotic positive to positive (reference: Lung fibrotic negative to negative ) compared with As LtoL . Moreover, the predicted mean of FVC and FEV1 in As HtoH (−0.09 units, 95% CI: −0.27, −0.09; −0.09 units, 95% CI: −0.17, −0.01) and As LtoH (−0.13 units, 95% CI: −0.30, −0.10; −0.13 units, 95% CI: −0.22, −0.04) was significantly lower than AS LtoL . Significant lung fibrotic changes including the increase of the alveolar septum thickness and collagen fiber deposition were observed upon 2 mg/L NaAsO 2 treatment for 12 weeks, and the damage was dose- and time-dependent. In vitro , sodium arsenite treatment promotes the epithelial-mesenchymal transition (EMT)-like changes of the normal human bronchial epithelial cells, including upregulation of several fibrotic and mesenchymal markers (fibronectin, MMP-2, and Snail) and cell migration. Inhibition of reactive oxygen species (ROS) and MMP-2 impaired the arsenic-induced EMT changes. Administration of a flavonoid, apigenin, inhibited EMT in vitro and pulmonary damages in vivo with the reduction of mesenchymal markers. Discussion: we demonstrated that continued exposure to arsenic causes lung fibrosis in humans and mice. Targeting lung epithelial cells EMT is effective on the development of therapeutic strategy. Apigenin is effective in the inhibition of arsenic-induced pulmonary fibrosis and EMT.

Lung Tumors in Mice Induced by "Whole-Life" Inorganic Arsenic Exposure at Human-Relevant Doses.

Arsenic Exposure During Juvenile and Puberty Significantly Affected Reproductive System Development of Female SD Rats

In Utero Exposure to Arsenic Alters Lung Development and Genes Related to Immune and Mucociliary Function in Mice

In utero exposure to arsenite contributes to metabolic and reproductive dysfunction in male offspring of CD-1 mice

Fetal Onset of Aberrant Gene Expression Relevant to Pulmonary Carcinogenesis in Lung Adenocarcinoma Development Induced by in Utero Arsenic Exposure

Lung developmental is altered after inhalation exposure to various concentrations of calcium arsenate

Arsenic, Stem Cells, and the Developmental Basis of Adult Cancer.

The Distribution in Tissues and Urine of Arsenic Metabolites after Subchronic Exposure to Dimethylarsinic Acid (DMA V ) in Rats

Effects of Inorganic Arsenic on the Rat and Mouse Urinary Bladder

Dose-dependent urinary phenotype of inorganic arsenic methylation in mice with a focus on trivalent methylated metabolites

Intrauterine exposure of mice to arsenite induces abnormal and transgenerational glycometabolism

Imbalanced Immune Responses Involving Inflammatory Molecules and Immune-Related Pathways in the Lung of Acute and Subchronic Arsenic-Exposed Mice.

Low Level Arsenite Exposures Suppress the Development of Bone Marrow Erythroid Progenitors and Result in Anemia in Adult Male Mice

Oral arsenite exposure induces inflammation and apoptosis in pulmonary tissue: acute and chronic evaluation in young and adult mice

Differential Effects of Arsenic in Drinking Water on Mouse Hepatic and Intestinal Heme Oxygenase-1 Expression

Intergenerational arsenic exposure on the mouse epigenome and metabolic physiology

Molecular mechanism of the increased tissue uptake of trivalent inorganic arsenic in mice with type 1 diabetes mellitus.

Arsenic-induced Changes in the Gene Expression of Lung Epithelial L2 Cells: Implications in Carcinogenesis

Inorganic arsenic exposure during pregnancy affects post-natal growth, blood parameters, and organ development of mice offspring

Distribution of speciated arsenicals in mice exposed to arsenite at the early life.

Arsenic exposure and lung fibrotic changes-evidence from a longitudinal cohort study and experimental models